Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MYRIAD GENETICS INCMYGN · Entity 5953 | Chief Operating Officer | September 30, 2020 | October 01, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MYRIAD GENETICS INC
Report date September 30, 2020 · Filed October 01, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 169,040 |
Reported balance
After 2020-09-30 transaction · row 1
1 source rowRow 1 · 2020-09-30 · Disposition to issuer · Disposed 6,653 · Balance 169,040 F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2020 Filed Oct 1, 2020 21:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $13.04 | $86,755.12 |
DisclosureSEC source: 0001644335-20-000010 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,040 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 26, 2020 Filed Sep 28, 2020 16:52 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 4,546 | $12.44 | $56,552.24 |
DisclosureSEC source: 0001644335-20-000008 · edgardoc.xml · nonDerivative · entry 4 Ford Alexander · CIK 0001644335 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,693 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2020 Filed Sep 28, 2020 16:52 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,267 | $12.44 | $65,521.48 |
DisclosureSEC source: 0001644335-20-000008 · edgardoc.xml · nonDerivative · entry 3 Ford Alexander · CIK 0001644335 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,239 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2020 Filed Sep 28, 2020 16:52 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $12.44 | $82,763.32 |
DisclosureSEC source: 0001644335-20-000008 · edgardoc.xml · nonDerivative · entry 2 Ford Alexander · CIK 0001644335 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,506 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 24, 2020 Filed Sep 28, 2020 16:52 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 41,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001644335-20-000008 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,159 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 25, 2019, subject to accomplishment of pre-determined financial performance requirements. On September 24, 2020, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Companys common stock, and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 13:56 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 2,804 | $13.78 | $38,630.43 |
DisclosureSEC source: 0001644335-20-000006 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,159 Read SEC document |
| August 12, 2020 Filed Aug 17, 2020 20:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 11,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001644335-20-000004 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,963 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 50% on August 25, 2021, and 50% on August 25, 2022. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 19:39 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 7,273 | $30.00 | $218,190.00 |
DisclosureSEC source: 0001644335-20-000002 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,438 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 26, 2019 Filed Dec 27, 2019 17:47 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 1,307 | $0.00 Strike: $15.98 | $0.00 |
DisclosureSEC source: 0001644335-19-000006 · edgardoc.xml · derivative · entry 2 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,693 Underlying: Common Stock · 1,307 shares Expires 2020-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 26, 2019 Filed Dec 27, 2019 17:47 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Exercise / conversionCommon Stock | 1,307 | $15.98 | $20,885.86 |
DisclosureSEC source: 0001644335-19-000006 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 22:29 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 1,830 | $28.63 | $52,392.90 |
DisclosureSEC source: 0001644335-19-000004 · edgardoc.xml · nonDerivative · entry 2 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,404 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 22:29 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $28.63 | $190,475.39 |
DisclosureSEC source: 0001644335-19-000004 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,234 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 20:48 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $29.93 | $199,124.29 |
DisclosureSEC source: 0001644335-19-000002 · edgardoc.xml · nonDerivative · entry 3 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,887 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 20:48 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 5,267 | $29.93 | $157,641.31 |
DisclosureSEC source: 0001644335-19-000002 · edgardoc.xml · nonDerivative · entry 2 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,540 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 20:48 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 47,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001644335-19-000002 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MWH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,807 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 19, 2018, subject to accomplishment of pre-determined financial performance requirements. On September 25, 2019, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 13:02 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $46.00 | $306,038.00 |
DisclosureSEC source: 0001644335-18-000008 · edgardoc.xml · nonDerivative · entry 2 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,524 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 13:02 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 1,830 | $46.00 | $84,180.00 |
DisclosureSEC source: 0001644335-18-000008 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,177 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:50 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 6,653 | $46.65 | $310,362.45 |
DisclosureSEC source: 0001644335-18-000006 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,007 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:14 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001644335-18-000004 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,660 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 18:21 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 1,830 | $46.35 | $84,820.50 |
DisclosureSEC source: 0001644335-18-000002 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,660 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| November 13, 2017 Filed Nov 14, 2017 22:02 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | SaleCommon Stock | 3,031 | $31.64 | $95,897.20 |
DisclosureSEC source: 0001644335-17-000008 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,769 Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 21:23 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 1,937 | $36.18 | $70,080.66 |
DisclosureSEC source: 0001644335-17-000006 · edgardoc.xml · nonDerivative · entry 2 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,800 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 21:23 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 7,043 | $36.18 | $254,815.74 |
DisclosureSEC source: 0001644335-17-000006 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,737 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2017 Filed Sep 19, 2017 21:48 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 1,937 | $33.05 | $64,017.85 |
DisclosureSEC source: 0001644335-17-000004 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,780 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 20:44 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001644335-17-000002 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,717 F1 · kind: Consists of performance stock units granted pursuant to the Company?s 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 14, 2016, subject to accomplishment of pre-determined financial performance requirements. On September 13, 2017, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 30, 2017, 25% on September 30, 2018, 25% on September 30, 2019, and 25% on September 30, 2020. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:55 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 1,937 | $20.58 | $39,863.46 |
DisclosureSEC source: 0001644335-16-000012 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,213 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2016 Filed Sep 20, 2016 12:52 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Disposition to issuerCommon Stock | 1,335 | $20.92 | $27,928.20 |
DisclosureSEC source: 0001644335-16-000010 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,150 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.